Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) – Not A Clear Buying Opportunity?
Cerevel Therapeutics Holdings Inc (CERE) concluded trading on Wednesday at a closing price of $44.96, with 15.03 million shares of worth about $675.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.82% during that period and on July 31, 2024 the price saw […]
Tomorrow Is Not Likely To Be Same For Cerevel Therapeutics Holdings Inc (CERE)
Cerevel Therapeutics Holdings Inc (CERE) concluded trading on Thursday at a closing price of $44.40, with 7.02 million shares of worth about $311.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.69% during that period and on July 25, 2024 the price saw […]
Cerevel Therapeutics Holdings Inc (CERE): Insights At A Glance
Cerevel Therapeutics Holdings Inc (CERE) concluded trading on Wednesday at a closing price of $40.35, with 4.68 million shares of worth about $188.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.41% during that period and on Wednesday the price saw a loss […]
Value Hunters: Look To Cerevel Therapeutics Holdings Inc (CERE)
Currently, there are 181.36M common shares owned by the public and among those 87.51M shares have been available to trade. The company’s stock has a 5-day price change of -4.61% and -6.70% over the past three months. CERE shares are trading -6.70% year to date (YTD), with the 12-month market performance up to 22.25% higher. […]
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE): Reassessing Prospects
Cerevel Therapeutics Holdings Inc (CERE) concluded trading on Thursday at a closing price of $42.93, with 4.02 million shares of worth about $172.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 100.70% during that period and on Thursday the price saw a loss […]
Value Hunters: Look To Cerevel Therapeutics Holdings Inc (CERE)
Fidelity Management & Research Co recently announced the acquisition of new stake in Cerevel Therapeutics Holdings Inc (NASDAQ:CERE). The institutional investor has increased its shareholding in the Healthcare company by 0.49% to 23.03 million shares with purchase of 0.11 million shares. This fresh investment now brings its stake to 12.77% valued currently at $597.05 million. […]
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) Loses -1.68% From High. Why That Could Change?
Fidelity Management & Research Co recently announced the acquisition of new stake in Cerevel Therapeutics Holdings Inc (NASDAQ:CERE). The institutional investor has increased its shareholding in the Healthcare company by 0.49% to 23.03 million shares with purchase of 0.11 million shares. This fresh investment now brings its stake to 12.99% valued currently at $544.55 million. […]
